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The asexual  erythrocytic  cycle responsible for the clinical  manifestations  of 
malaria is perpetuated by merozoites which rupture out of infected erythrocytes 
and invade uninfected ones.  Interaction between the merozoites and receptors 
on  the  erythrocyte  surface  initiate  invasion  (1-3).  Chemical  or immunologic 
interference between the merozoite and its receptor could block the infection at 
this  point  in  the  life cycle.  Previously,  we  studied  the  characteristics  of the 
erythroycte surface that are required for interaction and subsequent invasion by 
Plasmodium knowlesi merozoites (3, 4). Erythrocytes which lacked Duffy blood 
group determinants  (Duffy negative erythrocytes)  (3) or had been treated with 
chymotrypsin  (4) were resistant  to  invasion.  With  the  recent  advances  in  in 
vitro cultivation ofPlasmodium falciparum (5, 6), it was possible to compare the 
erythrocyte  surface determinants  required for invasion  by P. falciparum,  the 
major malaria of man, and P. knowlesi, a monkey malaria that infects man. 
Materials and Methods 
Human erythrocytes (test cells) which either lacked a blood group determinant (Table I) or had 
been treated  with various enzymes  (Table II)  were  exposed  to P. falciparum  and P. knowlesi 
merozoites  in  vitro,  and  the  percentage  of  test  cells  infected  was  determined.  Chimpanzee 
erythrocytes infected with P. falciparum (Camp strain) and frozen in liquid nitrogen were thawed 
(7) on the day of the experiment. They contained approximately 50% infected erythroeytes and 
varied in viability from experiment to experiment. The infected cells were centrifuged in microhe- 
matocrit tubes. Cells from the upper half of the tubes, containing about 90% infected erythrocytes 
were mixed with test erythrocytes in a  ratio of 1 to 25 and cultured as previously described (6). 
Erythrocytes were removed from culture 48 h later, spread in a thin film on a slide, stained with 
Giemsa, and the percent of erythrocytes infected with young trophozoites (ring forms) determined. 
Rhesus  erythrocytes  that  are  refractory  to  invasion by P. falciparum  were  included  in  each 
experiment (Table I). In parallel experiments, samples of test erythrocytes were cultured with P. 
knowlesi-infected cells (3). Since P. falciparum merozoites were released after 48 h in culture and 
P. knowlesi within 1 h,  test erythrocytes were incubated at 35°C  for 48 h  before addition of P. 
knowlesi-infected cells. 
Source of  Human Erythrocytes.  Erythrocytes were collected in acid citrate dextrose (ACD) and 
maintained at 4 C. Erythrocytes from the Finnish En(a-)  (G.W.) and two controls arrived in ice 
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from Finland and were cultured on 2 separate days with each parasite. Some erythrocytes (Kell 
null, Jk[a-b-], Lu[a-b-], Ge[a-], S-s-U-, En[a-] [A.P., England],  and their controls) were ob- 
tained as frozen droplets in liquid  nitrogen. Control erythrocytes were from healthy individuals 
with a common blood group phenotype.  Erythrocytes were washed three times in culture media 
before use. 
Enzyme Treatment of  Human Erythrocytes.  Erythrocytes were treated with chymotrypsin and 
trypsin, and the enzymes were inhibited after treatment as described  previously (3, 4, 8).  For 
neuraminidase treatment, a 20% suspension  of erythrocytes in Tris-buffered  saline with 3.6 mM 
KCI, 1.6 mM CaCl2, and 1.2 mM MgSO4, pH 7.4, was incubated with 25 U/ml of neuraminidase 
(Vibrio cholerae, B grade, Calbiochem, San Diego, Calif.) at 37°C for 30 min. Control erythrocytes 
from the same individual were treated identically except that no enzyme was used. The enzyme 
effect on the erythrocytes was monitored in each experiment: (a) chymotrypsin, removal of Duffy 
blood group activity; (b)  neuraminidase,  76  -+  1.4  (SEM) percent reduction  in electrophoretic 
mobility; (c) trypsin, 34 +_ 1.4 (SEM) percent reduction  in electrophoretic  mobility and removal of 
MN blood ~rouD activity. 
Results 
Human  erythrocytes lacking specific blood group determinants were all sus- 
ceptible to invasion by P. falciparum,  including erythrocytes with blood group 
phenotypes  (Fy[a-b-]  and S-s-U-) characteristic of black African populations 
(Table  I).  The  two  erythrocyte  samples  of the  En(a-)  phenotype  showed  a 
reduction in invasion by P. falciparum.  Since a  twofold decrease in invasion is 
within the range of variation between different individuals,  it is not known if 
the  reduced  invasion  was  caused  by  the  En(a-)  phenotype  or  some  other 
unrelated erythrocyte factor. In contrast to the small reduction in susceptibility 
of En(a-)  cells to P. falciparum, Duffy negative cells (Fy[a-b-])  are refractory 
to  infection  by P.  knowlesi  and  rhesus  cells  are  refractory to  infection  by P. 
falciparum  (Table I). 
The pattern of resistance of enzyme-treated human  erythrocytes to infection 
differed for P. falciparum and P. knowlesi (Table II). Chymotrypsin (0.1 mg/ml) 
treatment blocked infection by P. knowlesi but had no influence on infection by 
P.  falciparum.  Conversely,  trypsin  or  trypsin  plus  neuraminidase  caused  a 
marked  reduction  in  infection  by P.  falciparum  but  little  or  no  change  in 
susceptibility to P. knowlesi. Neuraminidase also caused a significant reduction 
in infection by P. falciparum, although the effect was less than that of trypsin or 
trypsin plus neuraminidase.  Neuraminidase treatment did not block infection 
by P. knowlesi. 
Discussion 
In a previous study we observed directly the interaction between erythrocytes 
and P. knowlesi merozoites (9). It consisted of attachment of the merozoite to the 
erythrocyte  membrane  followed  by  deformation  and  invasion.  None  of these 
events occurred when susceptible human erythrocytes were treated with chymo- 
trypsin  (Mason,  S.  J.,  L.  H.  Miller,  and  J.  A.  Dvorak.  Unpublished  data.), 
indicating  that  the  receptor necessary  for attachment  of P. knowlesi  was  re- 
moved.  In the  present  study chymotrypsin treatment  (0.1  mg/ml) that blocks 
invasion byP. knowlesi had no effect on invasion byP. falciparum. On the other 
hand, treatment of human  erythrocytes with trypsin or neuraminidase reduces 
invasion  by P. falciparum  but  not  by P.  knowlesi.  If P. falciparum  invades 
erythrocytes by a  similar mechanism to P. knowlesi, then infection of enzyme- MILLER ET  AL.  BRIEF  DEFINITIVE REPORT  279 
TABLE I 
The Susceptibility of Human Erythrocytes Lacking Various Blood Group Antigens to 
Invasion by P. falciparum and P. knowlesi 
Percent infected erythrocytes 
Blood group of (number studied) 
Test cells  P. falciparum  P. knowlesi 
Test cell  Control  Test cell  Control 
ABO null  (1)*  2.1  2.2  10.3  7.9 
Rh null  (1)*  2.0  2.2  10.7  7.9 
Kell null  (1)*  1.8  1.4  20.3  14.8 
Jk (a-b-)  (1)*  2.6  1.4  21.3  14.6 
Lu (a-b-)  (1)*  1.9  1.4  13.3  14.6 
Tn (1)  5.7  5.4  5.2  4.4 
Ge (a-) (1)  10.1  12.7  7.3  7.3 
S-s-U- (3)  7.4  1.3(8.5)$  8.5  7.7 
En (a-) (G.W., Finland)  4.8  10.3  6.8  9.9 
En (a-) (A.P., England)  4.9  12.7  6.3  7.3 
Fy (a-b-)  (4)  8.4  7.7  <0.1  13.0 
Rhesus (Macuc~ mulatta)  (5)  -<0.1  9.8  20.8  7.5 
* The lower percent infection of ABO null, Rh null  Kell null, Jk(a-b-),  Lu(a-b-),  and their controls byP. falciparum  resulted 
because  the chimpanzee  erythrocytes,  containing  50% P. falciparum-infected  cells,  were not concentrated  by centrifugation 
before mixing with these cells. 
Frozen cells  from one control were run on that day. The number in  parenthesis is  the mean percent infection for  fresh cells  from 
six people run on that same day. 
TABLE  II 
The Effect of Enzyme Treatment of Human Erythrocytes on Invasion by P. falciparum 
and P. knowlesi 
Enzyme 
Reduction of erythrocyte invasion* mean ±  SEM (no.  of exp) 
P. falciparum  P. knowlesi 
% 
Chymotrypsin, 0.1 mg/ml  -2.3  ±  4 (3)  90 (1)~t 
Neuraminidase, 25 U/ml  54 ±  8 (6)§  -9 ±  21 (3) 
Trypein, 1 mg/ml  78 ±  3 (6)§  2.5 ±  11 (4) 
Trypsin plus neuraminidase  93 ±  2 (2)  26 ±  15 (2) 
* Percent reduction  = (Percent infection of control cells) -  (percent infection of enzyme-treated cells)  x  100. 
(percent infection of centrol cells) 
~; The  resistance  of chymotrypsin  (0.1  mg/ml)  treated  erythrocytes  to  invasion  by P.  knowlesi  in  one  parallel  experiment 
corresponded to the results of published data for six experiments under similar conditions (95 ±  2.5 [SD] percent reduction  in 
invasion) (3, 4, 8). 
§ P  <  0.01  Comparison of invasion of control and enzyme-treated erythrocytes by the paired t test. 
treated erythrocytes  by one but not the other parasite would suggest that the 
initial recognition phase is blocked by treatment with proteolytic enzymes and 
that different proteins or glycoproteins are involved in the recognition of each 
parasite.  Moreover, the observation that erythrocytes remain susceptible to one 
of the two parasites after enzyme treatment indicates that the enzyme does not 
cause a nonspecific toxic effect. 
We can speculate as to the nature of the P, falciparum-specific determinant(s) 
from the changes in the erythrocyte  surface after enzyme treatments.  As indi- 
cated by periodic acid Schiff staining of sodium dodecyl sulfate-polyacrylamide 
gels  of enzyme-treated  erythrocytes,  trypsin  (1  mg/rnl)  removes  more  of the 
surface sialoglycopeptides  (e.g.,  from glycophorins A  and B) than does chyrno- 
trypsin (0.1 mg/ml) (8, 10). Trypsin (1 mg/ml)but not chymotrypsin (0.1 mg/rnl) 
causes reduction of invasion by P. falciparum.  Removal of sialic acid by neura- 280  MILLER  ET  AL.  BRIEF  DEFINITIVE  REPORT 
minidase treatment  also  reduced infection.  It  is  possible,  therefore,  that  a 
sialoglycopeptide is the erythrocyte receptor for P. falciparum merozoites. Gly- 
cophorin  A  cannot  be  the  sole  receptor  for P.  falciparum,  since  infection  of 
En(a-)  cells,  which  lack  this  sialoglycoprotein  (11,  12),  was  not  completely 
inhibited.  Further investigations with purified erythrocyte membrane glycopro- 
teins may resolve the nature of the receptor for P. falciparum. 
Summary 
Human erythrocytes lacking various blood group determinants were suscepti- 
ble to invasion by Plasmodium falciparum  including Duffy-negative erythro- 
cytes that are refractory to invasion by Plasmodium  knowlesi.  Erythrocytes 
treated with trypsin or neuraminidase had reduced susceptibility to P. falcipa- 
rum and normal susceptibility to P. knowlesi. Chymotrypsin treatment (0.1 mg! 
ml) blocked invasion only by P. knowlesi.  The differential  effect of enzymatic 
cleavage  of determinants  from the  erythrocyte  surface  on  invasion  by  these 
parasites suggests that P. falciparum  and P. knowlesi  interact with different 
determinants on the erythrocyte surface. 
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